Drug Type Small molecule drug |
Synonyms Diastabol, Miglibay, Miglitol (JP17/USAN/INN) + [12] |
Target |
Mechanism α-glucosidase inhibitors(Acidic alpha-glucosidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date NL (23 Jul 1996), |
Regulation- |
Molecular FormulaC8H17NO5 |
InChIKeyIBAQFPQHRJAVAV-ULAWRXDQSA-N |
CAS Registry72432-03-2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | JP | 11 Oct 2005 | |
Diabetes Mellitus, Type 2 | NL | - | 23 Jul 1996 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Noninsulin-Dependent, 2 | Phase 3 | JP | 07 Jun 2006 | |
Diabetes Mellitus, Type 1 | Phase 3 | JP | 21 Sep 2005 | |
Obesity | Phase 2 | US | - |
Not Applicable | - | - | olnubzyuzi(oekdgefvzh) = jhyerczemd ayklkngrws (oxxkvwekcn ) View more | - | 01 Jun 2020 | ||
olnubzyuzi(oekdgefvzh) = vnpcmvzmzn ayklkngrws (oxxkvwekcn ) View more | |||||||
Not Applicable | 41 | ndhmmuciru(ckcdktndbl) = jpnnmckuem fbzenbqwpg (mkmqmrqhvz, 0.11) View more | Positive | 24 Sep 2013 | |||
Sitagliptin | ndhmmuciru(ckcdktndbl) = rojlegehwk fbzenbqwpg (mkmqmrqhvz, 0.17) View more |